Introduction {#sec0005}
============

In recent times, there has been a considerable increase in the use of aortic bioprostheses for treating aortic valve disease, and this tendency is likely to continue in the near future. Worldwide, more than 200,000 surgical aortic valve replacements are performed each year \[[@bib0005]\]. Prosthetic valve endocarditis (PVE) is associated with high mortality and its incidence has increased over the past years, mainly due to the increasing use of implanted medical devices. *Staphylococcus aureus* and coagulase-negative staphylococcus are the most common microorganisms associated with PVE \[[@bib0010]\]. *Micrococcus* species are usually regarded as contaminants from skin and mucous membranes that rarely cause infectious diseases such as bacteremia, endocarditis, pneumonia and septic arthritis \[[@bib0015]\]. *Micrococcus luteus* is a rare cause of infective prosthetic valve endocarditis. To our knowledge, only 18 cases of *M. luteus* prosthetic valve endocarditis have been described, none in the English literature \[[@bib0020],[@bib0025]\].

Case description {#sec0010}
================

A 54-year old female was brought to the hospital after an unwitnessed fall and fever. Past medical history was relevant for an aortic valve replacement with bioprosthetic valve complicated by complete heart block requiring permanent pacemaker placement five years before presentation. On admission, she was found with a temperature of 39.6 C, a heart rate of 100 bpm and leukocytosis 27.4 k/mm^3^. Physical exam was unremarkable, except for a holosystolic murmur best audible over sternal border bilaterally and chronic venous insufficiency in lower extremities. Initial laboratories showed a procalcitonin of 23.9 ng/mL and a CRP of 12.1 mg/dL. Urinalysis did not show signs of infection, chest x-rays were negative for consolidations, and a viral panel was negative for respiratory viruses including RSV and influenza. She was started on broad-spectrum antibiotics: vancomycin and meropenem. Subsequently, blood cultures grew *Micrococcus luteus*, which was considered a skin contaminant at that point. However, after 5 days of broad-spectrum antibiotics, fever persisted. Given the presence of fever, positive blood cultures and a systolic murmur, infective endocarditis due to *M. luteus* was suspected. A transesophageal echocardiogram was performed, demonstrating small vegetation attached to the posterior leaflet. The patient was started on vancomycin 1750 mg every 24 h and rifampin 600 mg every 24 h. Her condition improved within the first few days, she became afebrile and white blood cell count improved. Follow-up blood cultures were negative. She received a course of 8 weeks of vancomycin and rifampicin. Regular clinical follow-up was normal.

Discussion {#sec0015}
==========

Prosthetic valves account for up to 34 % of all cases of infective endocarditis and it is accompanied by hospital mortality as high as 50 %. The microbiology of PVE is very different from native valve endocarditis (NVE), moreover, the microbiology of early-onset PVE (\<2 months), intermediate-onset PVE (2--12 months) and late-onset PVE (\>12 months) are also different. In the report by Lee \[[@bib0030]\] the most frequent infecting organisms after 1 year were *Staphylococcus aureus* (30 %), nonenterococcal streptococci (25 %, with 16 % viridans), coagulase-negative staphylococcus (13 %) and Enterococcus (10 %).

*Micrococcus* species, members of the family Micrococcaceae, are gram-positive cocci, catalase-positive, arranged in tetrad clusters. They can be differentiated from Staphylococcus due to their inability to produce acid from glucose in anaerobiosis, their resistance to lysostaphin and furazolidone, their sensibility to bacitracin, and positive modified oxidase test \[[@bib0025]\]. *M. luteus* is commonly regarded as a contaminant from the skin and mucous membranes \[[@bib0015]\]. Although of low virulence, it has been previously documented as a pathogen capable to colonize prosthetic valves and native valves in immunocompromised patients \[[@bib0035],[@bib0040],[@bib0050]\].

*Micrococcus* species have the capability to form biofilms with a prosthetic material, which could explain why most of the reported cases are with prosthetic valves \[[@bib0040]\]. In biofilms, cells grow in multicellular aggregates that are encased in an extracellular matrix produced by the bacteria. Formation of biofilms on medical devices often results in difficult-to-treat infections, mainly due to the numerous benefits that a bacterial community might obtain from the formation of biofilms including resistance to antibiotics, protection from protozoan grazing, and protection against host defenses \[[@bib0045]\].

There is no defined therapeutic regimen for infective endocarditis. In contrast to staphylococci, it is usually penicillin-sensitive and also has been reported to be susceptible to aminoglycosides, clindamycin, tetracycline, ofloxacin, ciprofloxacin, trimethoprim-sulfamethoxazole, rifampin, and fusidic acid \[[@bib0015],[@bib0055]\]. Most of the previously reported cases, including this case, were successfully treated with a combination of vancomycin and rifampin. This regimen was selected based on documented susceptibilities and the ability of rifampin and vancomycin to penetrate biofilms \[[@bib0060],[@bib0065]\].

This case exemplifies how human activity (in this context advances in medicine and the increasing use of bioprosthetic medical devices) influences our Milieu intérieur and has an impact on evolutionary adaptation and positive natural selection, favoring that bacteria that are not usually pathogenic, such as *Micrococcus luteus,* are now more fit to cause disease in immunocompetent patients.
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